Due to the lack of more efficient diagnostic tools for monkeypox, its spread remains unchecked, presenting a formidable challenge to global health. While the high efficacy of deep learning models for monkeypox diagnosis has been demonstrated in related studies, the overlook of inference speed, the parameter size and diagnosis performance for early-stage monkeypox renders the models inapplicable in real-world settings. To address these challenges, we proposed an ultrafast and ultralight network named Fast-MpoxNet. Fast-MpoxNet possesses only 0.27M parameters and can process input images at 68 frames per second (FPS) on the CPU. To counteract the diagnostic performance limitation brought about by the small model capacity, it integrates the attention-based feature fusion module and the multiple auxiliary losses enhancement strategy for better detecting subtle image changes and optimizing weights. Using transfer learning and five-fold cross-validation, Fast-MpoxNet achieves 94.26% Accuracy on the Mpox dataset. Notably, its recall for early-stage monkeypox achieves 93.65%. By adopting data augmentation, our model's Accuracy rises to 98.40% and attains a Practicality Score (A new metric for measuring model practicality in real-time diagnosis application) of 0.80. We also developed an application system named Mpox-AISM V2 for both personal computers and mobile phones. Mpox-AISM V2 features ultrafast responses, offline functionality, and easy deployment, enabling accurate and real-time diagnosis for both the public and individuals in various real-world settings, especially in populous settings during the outbreak. Our work could potentially mitigate future monkeypox outbreak and illuminate a fresh paradigm for developing real-time diagnostic tools in the healthcare field.